ATE86854T1 - Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen. - Google Patents

Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.

Info

Publication number
ATE86854T1
ATE86854T1 AT90870135T AT90870135T ATE86854T1 AT E86854 T1 ATE86854 T1 AT E86854T1 AT 90870135 T AT90870135 T AT 90870135T AT 90870135 T AT90870135 T AT 90870135T AT E86854 T1 ATE86854 T1 AT E86854T1
Authority
AT
Austria
Prior art keywords
fatty acid
treatment
oxygen
retroviral infections
acid analogs
Prior art date
Application number
AT90870135T
Other languages
English (en)
Inventor
Jeffrey Ivan Gordon
Steven Paul Adams
Robert Otto Heuckeroth
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Application granted granted Critical
Publication of ATE86854T1 publication Critical patent/ATE86854T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/125Saturated compounds having only one carboxyl group and containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40Unsaturated compounds
    • C07C59/58Unsaturated compounds containing ether groups, groups, groups, or groups
    • C07C59/60Unsaturated compounds containing ether groups, groups, groups, or groups the non-carboxylic part of the ether being unsaturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Emergency Medicine (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT90870135T 1989-09-01 1990-08-31 Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen. ATE86854T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/402,094 US5073571A (en) 1988-06-16 1989-09-01 Method of inhibiting virus

Publications (1)

Publication Number Publication Date
ATE86854T1 true ATE86854T1 (de) 1993-04-15

Family

ID=23590495

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90870135T ATE86854T1 (de) 1989-09-01 1990-08-31 Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.

Country Status (8)

Country Link
US (1) US5073571A (de)
EP (1) EP0415902B1 (de)
JP (1) JPH0714875B2 (de)
AT (1) ATE86854T1 (de)
CA (1) CA2024489A1 (de)
DE (1) DE69001107T2 (de)
DK (1) DK0415902T3 (de)
ES (1) ES2055407T3 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0445097T3 (da) * 1990-02-26 1996-09-16 Univ Washington Fremgangsmåde til N-myristoylering af protein
US5236955A (en) * 1992-04-10 1993-08-17 Washington University Anti-fungal agent
US6602861B1 (en) * 1992-04-16 2003-08-05 Research Corporation Technologies, Inc. Acylated phospholipid drugs
GB9212276D0 (en) * 1992-06-10 1992-07-22 Harper David R Anti-viral agents
GB2267642B (en) * 1992-06-10 1996-04-24 British Tech Group Anti-viral agents
US5463152A (en) * 1994-12-08 1995-10-31 E. I. Du Pont De Nemours And Company Halofluorocarbon hydrogenolysis
US5599947A (en) * 1993-01-14 1997-02-04 G. D. Searle & Co. Fatty acid analogs and prodrugs
US5859052A (en) * 1993-01-14 1999-01-12 G. D. Searle & Co. Fatty acid analogs and prodrugs
DE10063111A1 (de) * 2000-12-18 2002-06-20 Bayer Ag Replikationsassay zur Auffindung antiviraler Substanzen
US20120028335A1 (en) 2010-07-28 2012-02-02 Life Technologies Corporation Anti-viral azide-containing compounds
US20130209550A1 (en) 2010-07-28 2013-08-15 Life Technologies Corporation Anti-Viral Azide Containing Compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2262514A1 (en) * 1974-03-01 1975-09-26 Alary Josette Reticulo-endothelial stimulating compsn. - contg. sodium oleate, sodium stearate and neutralised olive oil
US4513005A (en) * 1981-06-18 1985-04-23 Lilly Industries Limited SRS-A antagonists
US4740588A (en) * 1986-08-07 1988-04-26 Washington University Novel substrate peptides
US4709012A (en) * 1986-08-07 1987-11-24 Washington University Novel inhibitor peptides

Also Published As

Publication number Publication date
DE69001107D1 (de) 1993-04-22
EP0415902B1 (de) 1993-03-17
JPH03109322A (ja) 1991-05-09
JPH0714875B2 (ja) 1995-02-22
CA2024489A1 (en) 1991-03-02
DE69001107T2 (de) 1993-10-07
ES2055407T3 (es) 1994-08-16
DK0415902T3 (da) 1993-04-19
US5073571A (en) 1991-12-17
EP0415902A1 (de) 1991-03-06

Similar Documents

Publication Publication Date Title
FI881646A0 (fi) Nya fasta icke-nedbrytbara fettliknande foereningar.
EP0609968A3 (de) Zusammensetzungen welche Teilestern von Alginsäure enthalten.
DE3789274D1 (de) Verfahren zur Herstellung von zyklischen Estern hoher Reinheit.
AU2867089A (en) (cycloalkylamino)methylenebis(phosphonic acid) and medicines containing the same as an active ingredient
ATE72988T1 (de) Fettsaeure-zusammensetzungen.
NO893021D0 (no) Fremgangsmaate for fremstilling av en biologisk aktiv forbindelse, fr 901228.
ATE121939T1 (de) Ascorbinsäure-tocopheryl-phosphatdiester zur hemmung der maillard-reaktion.
DE3685797D1 (de) Clausverfahren zur herstellung von schwefel in gegenwart erhoehter sauerstoffmengen.
DE60004217D1 (de) Sulphostinanaloga und verfahren zur herstellung von sulphostin und analoga davon
ATE86854T1 (de) Sauerstoff- oder schwefelsubstituierte fettsaeureanaloga zur behandlung retroviraler infektionen.
DE3884517D1 (de) Biologisch aktive carbonsaeureester.
EP0642525A1 (de) Chemische Verbindungen.
DE69212925D1 (de) Polymerisationsinhibitoren für Acrylsäure und Ester
PT88994A (pt) Processo para a preparacao de 2',3'-didesoxi-2'-fluoro-nucleosidos e de composicoes farmaceuticas que os contem
DE59003144D1 (de) Destillationsanlage zur Herstellung von Wasserstoff-Peroxid.
EP0293751A3 (en) Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia
DE69427955D1 (de) Verfahren zur Herstellung von 2,2-Difluorketensilylacetalen und alpha,alpha-Difluor-beta -Silyloxy-1,3-Dioxolan-4-Propansäureestern
AU631738B2 (en) Bis(alkyl-substituted-4-hydroxyphenylthio)alkane analogs as inhibitors of cataractogenesis
DK0441765T3 (da) Nye enzymsubstrater på basis af fedtsyreanaloger
ATE74346T1 (de) Alkensaeurederivate.
DE69108616D1 (de) 3.3'-Dithiobis (Propionsäuren) und Estern davon.
ES2062282T3 (es) Proceso de racemizacion de esteres del acido carboxilico opticamente activos.
GR75173B (de)
DE3888543D1 (de) Zusammensetzungen zur herstellung von gasdurchlässigen kontaktlinsen.
AT381724B (de) Vorrichtung zur herstellung glasig erstarrter schlacke

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee